Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin-incorporated fibrin–fibronectin matrix
Authors:
- Weiqiang LiuWLWeiqiang Liu
- Qiang AoQiang Ao
- Guangzhi WangGWGuangzhi Wang
- 30 September 2008
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 71 (3) , 374-378
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Evidence supporting the use of bone morphogenetic proteins for spinal fusion surgeryExpert Review of Medical Devices, 2008
- Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidenceOsteoporosis International, 2007
- BONE MORPHOGENETIC PROTEINS IN CLINICAL APPLICATIONSAnz Journal of Surgery, 2007
- Bone morphogenetic proteins for spinal fusionThe Spine Journal, 2005
- Carrier materials for spinal fusionThe Spine Journal, 2005
- Collagen sponges for bone regeneration with rhBMP-2Advanced Drug Delivery Reviews, 2003
- Bone grafts and bone morphogenetic proteins in spine fusionCell and Tissue Banking, 2002
- THE ROLE OF GROWTH FACTORS IN THE REPAIR OF BONEJournal of Bone and Joint Surgery, 2002
- Bone morphogenetic proteins in human bone regenerationEuropean Journal of Endocrinology, 2000
- Characterization of absorbable collagen sponges as rhBMP-2 carriersInternational Journal of Pharmaceutics, 1999